regend001
Cell therapyexperimental
Clinical trial activity
5 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 14, 2021 (NCT05657184)
Timeline
Indications
Mechanism of action
- bronchial cellsTissue restoration
bronchial cells tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06998706 | Phase 1 | Jun 30, 2025 | Jiao Tong University |
| NCT06987214 | Phase 1 | Jun 30, 2025 | Jiao Tong University |
| NCT06081621 | Phase 2 | Oct 20, 2023 | Chinese Academy of Medical Sciences, Jiao Tong University, Regend Therapeutics |
| NCT05638776 | Phase 2 | Jun 20, 2022 | Fudan University, Guangzhou Medical University, Huazhong University of Science and Technology, Jiao Tong University, Peking University, People's Liberation Army of China, Regend Therapeutics |
| NCT05657184 | Phase 1/Phase 2 (Phase 2) | May 14, 2021 | Chinese Academy of Medical Sciences, Guangzhou Medical University, Jiao Tong University, Regend Therapeutics |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiao Tong University | Academic/Hospital | 5 | 2 | 2 | 2021 |
| Regend Therapeutics | For profit | 3 | 3 | 1 | 2021 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 1 | 2021 |
| Guangzhou Medical University | Academic/Hospital | 2 | 0 | 1 | 2021 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2022 |
8 organizations
Page 1 / 1